<DOC>
	<DOCNO>NCT00576667</DOCNO>
	<brief_summary>The purpose study assess effect Rimonabant treatment histological feature Nonalcoholic Steatohepatitis ( NASH ) .</brief_summary>
	<brief_title>An Efficacy Safety Study Rimonabant Treatment Nonalcoholic Steatohepatitis ( NASH ) Patients Without Diabetes</brief_title>
	<detailed_description>The total duration per patient approximately 28 month include 24-month double-blind treatment period .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Patients diagnosis NASH Excessive alcohol use Presence diabetes mellitus Other chronic liver disease Previous current hepatocellular carcinoma Use medication know cause steatosis Previous bariatric surgery Pregnancy breastfeed Presence severe medical psychological condition , opinion investigator , would compromise patient 's safe participation include uncontrolled serious psychiatric illness major depression within last 2 year , history severe psychiatric disorder . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>NASH</keyword>
	<keyword>chronic liver disease</keyword>
</DOC>